4.5 Review

Molecular insights into psychedelic drug action

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain

Nakul Ravi Raval et al.

Summary: This study showed that a single dose of psilocybin can lead to increased SV2A density and decreased 5-HT2AR density in the pig brain, suggesting a potential role in the antidepressant effects of psilocybin.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Neurosciences

A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics

Neil K. Savalia et al.

Summary: Studies have shown that serotonergic psychedelics like psilocybin and ketamine may relieve depression by promoting neural plasticity. Despite targeting distinct molecular receptors in the brain, the behavioral and neural effects of these compounds are similar, possibly by enhancing and suppressing membrane excitability at dendrites.

TRENDS IN NEUROSCIENCES (2021)

Article Biochemistry & Molecular Biology

Structural insights into the human D1 and D2 dopamine receptor signaling complexes

Youwen Zhuang et al.

Summary: This study presents cryo-EM structures of D1R-G(s) and D2R-G(i) signaling complexes with dopamine agonists, revealing insights into dopamine signaling, ligand selectivity, receptor activation, and G protein-coupling selectivity, providing valuable information for drug design targeting the dopaminergic system.
Article Cell Biology

Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice

Mario de la Fuente Revenga et al.

Summary: Clinical evidence shows that rapid and sustained antidepressant effects can be achieved with a single exposure to psychedelics. The study found that a single dose of the psychedelic DOI has fast-acting effects on the frontal cortex dendritic spine structure and accelerates fear extinction through the 5-HT2A receptor. Furthermore, DOI induces changes in chromatin organization, particularly at enhancer regions of genes involved in synaptic assembly, which overlap with genetic loci associated with schizophrenia, depression, and attention deficit hyperactivity disorder.

CELL REPORTS (2021)

Review Biochemistry & Molecular Biology

Biased ligands at opioid receptors: Current status and future directions

Tao Che et al.

Summary: The opioid crisis has led to a search for safer and more effective opioids. The discovery of biased opioid ligands offers a potential alternative, but questions remain about their therapeutic benefits. More research is needed in this important area to understand the implications of biased agonism.

SCIENCE SIGNALING (2021)

Review Neurosciences

Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics

Deborah Rudin et al.

Summary: New psychoactive stimulants and psychedelics still have a significant presence in the illicit new psychoactive substance market, with potential neurotoxic effects that may impact the brain's neurological system. However, the translation of preclinical data on NPS-induced neurotoxicity to humans remains uncertain.

EXPERIMENTAL NEUROLOGY (2021)

Editorial Material Neurosciences

The cranial windows of perception

Jeffrey F. DiBerto et al.

Summary: Psilocybin has been shown to have potentially rapid and enduring antidepressant effects. A study in Neuron demonstrates that psilocybin quickly induces dendritic spine formation in cortical layer V pyramidal neurons, providing a potential cellular mechanism for its therapeutic actions.

NEURON (2021)

Article Neurosciences

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo

Ling-Xiao Shao et al.

Summary: The study showed that psilocybin can induce rapid and lasting synaptic rewiring in the cortex, increasing spine size and density. This structural change may have potential implications for long-term integration of experiences and lasting beneficial actions.

NEURON (2021)

Article Multidisciplinary Sciences

LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1

Ramona M. Rodriguiz et al.

Summary: Recent evidence suggests that psychedelic drugs can have beneficial effects on anxiety, depression, and substance abuse. However, their hallucinogenic side-effects often limit their clinical use. LSD's psychedelic actions appear to require the activation of 5-HT2AR and interaction with beta Arr2.

SCIENTIFIC REPORTS (2021)

Article Chemistry, Medicinal

Investigation of the Structure-Activity Relationships of Psilocybin Analogues

Adam K. Klein et al.

Summary: This study investigated the pharmacological properties of tryptamine derivatives containing N,N-dialkyl substituents and a 4-hydroxy or 4-acetoxy group, revealing their similar potencies at 5-HT2A and 5-HT2B receptors. The compounds acted as full or partial agonists at 5-HT2 subtypes and induced LSD-like head twitches in mice. O-acetylation reduced the in vitro potency of the compounds but had little effect on their in vivo head twitch response potency, suggesting a prodrug mechanism.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Review Biochemistry & Molecular Biology

DARK Classics in Chemical Neuroscience: NBOMes

Christian B. M. Poulie et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Editorial Material Biochemistry & Molecular Biology

Psychedelic Psychiatry's Brave New World

David Nutt et al.

Article Biochemistry & Molecular Biology

Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT2A receptor

Antara A. Banerjee et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

Kuglae Kim et al.

Article Multidisciplinary Sciences

Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation

R. N. Moda-Sava et al.

SCIENCE (2019)

Article Biochemistry & Molecular Biology

5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology

Yao Peng et al.

Article Cell Biology

Psychedelics Promote Structural and Functional Neural Plasticity

Calvin Ly et al.

CELL REPORTS (2018)

Article Biochemistry & Molecular Biology

Crystal Structure of an LSD-Bound Human Serotonin Receptor

Daniel Wacker et al.

Article Clinical Neurology

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Anna Rickli et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)

Article Multidisciplinary Sciences

Structure-based discovery of opioid analgesics with reduced side effects

Aashish Manglik et al.

NATURE (2016)

Review Neurosciences

DREADDs for Neuroscientists

Bryan L. Roth

NEURON (2016)

Article Pharmacology & Pharmacy

In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1

Linda D. Simmler et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)

Review Pharmacology & Pharmacy

Psychedelics

David E. Nichols

PHARMACOLOGICAL REVIEWS (2016)

Article Biochemistry & Molecular Biology

PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

Wesley K. Kroeze et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)

Article Biochemistry & Molecular Biology

PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

Wesley K. Kroeze et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2c Agonists

Martin Hansen et al.

ACS CHEMICAL NEUROSCIENCE (2014)

Article Multidisciplinary Sciences

Structural Basis for Molecular Recognition at Serotonin Receptors

Chong Wang et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

Structural Features for Functional Selectivity at Serotonin Receptors

Daniel Wacker et al.

SCIENCE (2013)

Review Cardiac & Cardiovascular Systems

Biased Ligands for Better Cardiovascular Drugs Dissecting G-Protein-Coupled Receptor Pharmacology

Scott M. DeWire et al.

CIRCULATION RESEARCH (2011)

Article Multidisciplinary Sciences

Discovery of β-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy

John A. Allen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Biochemistry & Molecular Biology

Serotonin receptor signaling and regulation via β-arrestins

Laura M. Bohn et al.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)

Review Medicine, Research & Experimental

The Expanded Biology of Serotonin

Miles Berger et al.

ANNUAL REVIEW OF MEDICINE (2009)

Article Biochemistry & Molecular Biology

Ribosomal S6 Kinase 2 Directly Phosphorylates the 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptor, Thereby Modulating 5-HT2A Signaling

Ryan T. Strachan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Multidisciplinary Sciences

Predicting new molecular targets for known drugs

Michael J. Keiser et al.

NATURE (2009)

Article Multidisciplinary Sciences

Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling

Kelly A. Jones et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo

Cullen L. Schmid et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Pharmacology & Pharmacy

Functional selectivity and classical concepts of quantitative pharmacology

Jonathan D. Urban et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)

Article Biochemistry & Molecular Biology

Serotonin 5-HT2A receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism

Jason C. Parrish et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Multidisciplinary Sciences

p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling

DJ Sheffler et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Pharmacology & Pharmacy

Hallucinogens

DE Nichols

PHARMACOLOGY & THERAPEUTICS (2004)

Article Multidisciplinary Sciences

The human polyomavirus, JCV, uses serotonin receptors to infect cells

GF Elphick et al.

SCIENCE (2004)

Article Biochemistry & Molecular Biology

The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins

C Bécamel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction

ZQ Xia et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Pharmacology & Pharmacy

Serotonin 5-hydroxytryptamine(2A) receptor-coupled phospholipase C and phospholipase A(2) signaling pathways have different receptor reserves

DM Kurrasch-Orbaugh et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)